SCHEMBL21526078

SCHEMBL21526078

Cc1nc(C(=O)O)nc(NCC(=O)OC(C)(C)C)c1Cc1ccc(Cl)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ HTT P42858 3/20 0.38
▸ P2RX7 Q99572 2/20 0.38
▸ TLR7 Q9NYK1 1/20 0.37
▸ IDO1 P14902 2/20 0.37
▸ HPGD P15428 3/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ ROCK2 O75116 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ RPS6KA3 P51812 1/20 0.35
▸ PAK1 Q13153 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ PRKD2 Q9BZL6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21548808 0.92 HPGD (0.39) SMN1; SMN2HTTP2RX7IDO1HPGD
SCHEMBL21548811 0.90 HTT (0.46) SMN1; SMN2HTTP2RX7TLR7IDO1
SCHEMBL21548809 0.87 SMN1; SMN2 (0.43) SMN1; SMN2HTTP2RX7HPGDNPSR1
Hydrochloric Acid SCHEMBL21526024 0.87 SMN1; SMN2 (0.43) SMN1; SMN2HTTP2RX7HPGDNPSR1
SCHEMBL21548806 0.85 SMN1; SMN2 (0.44) SMN1; SMN2HTTP2RX7HPGDNPSR1
SCHEMBL21526049 0.84 SMN1; SMN2 (0.41) SMN1; SMN2HTTP2RX7TLR7HPGD
SCHEMBL21526073 0.84 SMN1; SMN2 (0.44) SMN1; SMN2HTTP2RX7HPGDNPSR1
Hydrochloric Acid SCHEMBL21526127 0.83 SMN1; SMN2 (0.43) SMN1; SMN2HTTP2RX7HPGDNPSR1
SCHEMBL21526097 0.82 HPGD (0.42) SMN1; SMN2HTTP2RX7TLR7IDO1
SCHEMBL20356749 0.82 SMN1; SMN2 (0.43) SMN1; SMN2HTTP2RX7TLR7HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3564216-B1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2021-10-27 — — EP disclosed
US-11034659-B2 Pyrimidine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-06-15 — — US disclosed
US-20200172494-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-06-04 — — US disclosed
EP-3564216-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-11-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034659-B2 Pyrimidine derivative GPR39, CFTR, TMEM109 SMN1; SMN2 2983/4885HTT 3973/4885P2RX7 137/4885
US-20200172494-A1 PYRIMIDINE DERIVATIVE GPR39, CFTR, TMEM109 SMN1; SMN2 2983/4885HTT 3973/4885P2RX7 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback